metoprolol has been researched along with Hypotension in 54 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Hypotension: Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ibutilide is a type III antiarrhythmic agent approved for the pharmacologic conversion of atrial fibrillation (AF) and atrial flutter (AFl)." | 9.12 | Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter. ( McPherson, CA; Mountantonakis, SE; Moutzouris, DA; Papaioannou, GN; Tiu, RV, 2006) |
| "Compare heart rate control between parenteral metoprolol and diltiazem and identify safety outcomes in the acute management of atrial fibrillation (AFib) with rapid ventricular response (RVR) in patients with heart failure with reduced ejection fraction (HFrEF)." | 8.31 | Acute rate control with metoprolol versus diltiazem in atrial fibrillation with heart failure with reduced ejection fraction. ( Allison-Aipa, T; Choi, M; Kapustova, K; Phan, B, 2023) |
| " Postoperatively, the patient had persistent sinus tachycardia that was initially unsuccessfully treated with metoprolol." | 7.70 | Treatment of milrinone-associated tachycardia with beta-blockers. ( Alhashemi, JA; Hooper, J, 1998) |
| " Based on the Chinese and International guidelines and the Chinese clinical practice, we are conducting this study (NCT03413410) to test the feasibility and tolerability of the metoprolol optimal dosing pathway by observing the percentage of patients achieving target dose in Chinese acute coronary syndrome (ACS) patients during hospitalisation." | 6.90 | Impact of metoprolol standard dosing pathway in Chinese patients with acute coronary syndrome: protocol for a multicentre prospective study. ( Chen, Y; Dong, W; Li, D; Liu, Y; Mu, Y; Wang, J; Zhou, H; Zhou, S, 2019) |
| "Ibutilide is a type III antiarrhythmic agent approved for the pharmacologic conversion of atrial fibrillation (AF) and atrial flutter (AFl)." | 5.12 | Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter. ( McPherson, CA; Mountantonakis, SE; Moutzouris, DA; Papaioannou, GN; Tiu, RV, 2006) |
| "The purpose of this study was to determine the incidence of ventricular tachycardia and fibrillation without hypotension or heart failure after treatment with recombinant tissue-type plasminogen activator (rt-PA), anatomic correlates of their development, the effect of immediate intravenous metoprolol on their occurrence and the outcome of patients with these arrhythmias." | 5.07 | Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: results from the Thrombolysis in Myocardial In ( Berger, PB; Frederick, MM; Podrid, PJ; Ruocco, NA; Ryan, TJ, 1993) |
| "Compare heart rate control between parenteral metoprolol and diltiazem and identify safety outcomes in the acute management of atrial fibrillation (AFib) with rapid ventricular response (RVR) in patients with heart failure with reduced ejection fraction (HFrEF)." | 4.31 | Acute rate control with metoprolol versus diltiazem in atrial fibrillation with heart failure with reduced ejection fraction. ( Allison-Aipa, T; Choi, M; Kapustova, K; Phan, B, 2023) |
| " We determined to examine the effect of ILE on haemodynamic recovery following induction of hypotension with the relatively hydrophilic β-blocker, metoprolol." | 3.76 | Intravenous lipid emulsion does not augment blood pressure recovery in a rabbit model of metoprolol toxicity. ( Browne, A; Cave, G; Harvey, M, 2010) |
| " In this case report we describe the use of high-dose insulin (10 IU/kg per hour) in a case of massive metoprolol ingestion (5g) in which hypotension was unresponsive to conventional therapies." | 3.75 | The use of high-dose insulin-glucose euglycemia in beta-blocker overdose: a case report. ( Hacket, LP; Isbister, GK; Page, C, 2009) |
| " Postoperatively, the patient had persistent sinus tachycardia that was initially unsuccessfully treated with metoprolol." | 3.70 | Treatment of milrinone-associated tachycardia with beta-blockers. ( Alhashemi, JA; Hooper, J, 1998) |
| "Three patients with ischaemic heart disease developed profound cardiac failure, hypotension and bradycardia during combined therapy with verapamil and beta-adrenergic blocking drugs." | 3.66 | Adverse interaction between beta-adrenergic blocking drugs and verapamil--report of three cases. ( Anderson, ST; Federman, J; Harper, RW; Laufer, E; Pitt, A; Wayne, VS, 1982) |
| " Based on the Chinese and International guidelines and the Chinese clinical practice, we are conducting this study (NCT03413410) to test the feasibility and tolerability of the metoprolol optimal dosing pathway by observing the percentage of patients achieving target dose in Chinese acute coronary syndrome (ACS) patients during hospitalisation." | 2.90 | Impact of metoprolol standard dosing pathway in Chinese patients with acute coronary syndrome: protocol for a multicentre prospective study. ( Chen, Y; Dong, W; Li, D; Liu, Y; Mu, Y; Wang, J; Zhou, H; Zhou, S, 2019) |
| "Beta-blockers substantially improve survival in patients with chronic heart failure (HF) with left ventricular systolic dysfunction, but concerns about cardiovascular adverse effects may deter physicians from prescribing this therapy." | 2.71 | Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials. ( Coffey, CS; Curtis, JP; Foody, JM; Hebert, PR; Ko, DT; Krumholz, HM; Sedrakyan, A, 2004) |
| "Hypotension is an important potential side effect." | 2.67 | Efficacy of cardioselective beta-adrenergic blockade with intravenously administered metoprolol in the treatment of supraventricular tachyarrhythmias. ( Amsterdam, EA; Kulcyski, J; Ridgeway, MG, 1991) |
| "The incidences of congestive heart failure, hypotension, AV blocks and ventricular arrhythmias were not significantly more common in the control group (8 vs." | 2.65 | Established beta-adrenergic receptor blocking therapy and acute myocardial infarction. A clinical study of risks and benefits. ( Berglund, U; Dahlström, U; Karlsson, E, 1980) |
| " Insulin was infused for a total of approximately 37 hours, most of which was dosed at 10 U/kg/hour; following discontinuation, serial serum insulin levels were drawn and remained at supraphysiologic levels for at least 24 hours and well above reference range for multiple days thereafter." | 1.56 | Persistent Hyperinsulinemia Following High-Dose Insulin Therapy: A Case Report. ( Bangh, SA; Cole, JB; Corcoran, JN; Jacoby, KJ; Olives, TD, 2020) |
| "Recipients of severe twin-to-twin transfusion syndrome (TTTS) may suffer from low cardiac output caused by myocardial hypertrophy and sudden postnatal drop in preload." | 1.51 | Beta blocker therapy in recipients of twin-to-twin transfusion syndrome. ( Franz, AR; Gruendler, K; Lorenz, L; Poets, CF; Schwarz, CE, 2019) |
| " The primary outcome measure was the rate of serious adverse events (SAE), defined as a complication of intravenous metoprolol resulting in transfer to a critical-care environment, a medical emergency team call or death." | 1.42 | Safety of intravenous metoprolol use in unmonitored wards: a single-centre observational study. ( Barrett, J; Cunningham, M; Hawdon, G; Kelly, D; Morris, A; Reeves, J, 2015) |
| " Beta-blocker dosages were titrated, and three patients achieved the target beta-blocker dosage established for stage A-C heart failure." | 1.34 | Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone. ( Earl, GL; Fitzpatrick, JM; Narula, J; Verbos-Kazanas, MA, 2007) |
| "Many of the arrhythmias other than ventricular fibrillation had little hemodynamic consequence and did not require treatment." | 1.28 | Associated reactions during and immediately after rtPA infusion. ( Linnik, W; Ramos, R; Tintinalli, JE, 1989) |
| " What remains to be solved is the dosage level." | 1.26 | Clinical experiences with prenalterol as an antidote to Beta-adrenoceptor blockade. ( Kulling, P, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (14.81) | 18.7374 |
| 1990's | 11 (20.37) | 18.2507 |
| 2000's | 20 (37.04) | 29.6817 |
| 2010's | 8 (14.81) | 24.3611 |
| 2020's | 7 (12.96) | 2.80 |
| Authors | Studies |
|---|---|
| Bannister, BE | 1 |
| Parry, DR | 1 |
| Pouliot, JD | 1 |
| Xiao, SQ | 1 |
| Ibarra, F | 1 |
| Cruz, M | 1 |
| Tekin, EE | 1 |
| Yeşiltaş, MA | 1 |
| Haberal, İ | 1 |
| Stone, KH | 1 |
| Reynolds, K | 1 |
| Davis, S | 1 |
| Van Tassell, BW | 1 |
| Gibson, CM | 1 |
| Kapustova, K | 1 |
| Phan, B | 1 |
| Allison-Aipa, T | 1 |
| Choi, M | 1 |
| Li, D | 1 |
| Dong, W | 1 |
| Liu, Y | 1 |
| Wang, J | 2 |
| Mu, Y | 1 |
| Zhou, H | 1 |
| Zhou, S | 1 |
| Chen, Y | 1 |
| Razzoli, M | 1 |
| Lindsay, A | 1 |
| Law, ML | 1 |
| Chamberlain, CM | 1 |
| Southern, WM | 1 |
| Berg, M | 1 |
| Osborn, J | 1 |
| Engeland, WC | 1 |
| Metzger, JM | 1 |
| Ervasti, JM | 1 |
| Bartolomucci, A | 1 |
| Corcoran, JN | 1 |
| Jacoby, KJ | 1 |
| Olives, TD | 1 |
| Bangh, SA | 1 |
| Cole, JB | 1 |
| Jacka, MJ | 1 |
| Guyatt, G | 1 |
| Mizera, R | 1 |
| Van Vlymen, J | 1 |
| Ponce de Leon, D | 1 |
| Schricker, T | 1 |
| Bahari, MY | 1 |
| Lv, B | 1 |
| Afzal, L | 1 |
| Plou García, MP | 1 |
| Wu, X | 1 |
| Nigro Maia, L | 1 |
| Arrieta, M | 1 |
| Rao-Melacini, P | 1 |
| Devereaux, PJ | 2 |
| Calzadilla, A | 1 |
| Badiye, A | 1 |
| Ghodsizad, A | 1 |
| Bernstein, J | 1 |
| Campos, M | 1 |
| Mirsaeidi, M | 1 |
| Gruendler, K | 1 |
| Schwarz, CE | 1 |
| Lorenz, L | 1 |
| Poets, CF | 1 |
| Franz, AR | 1 |
| Kelly, D | 1 |
| Hawdon, G | 1 |
| Reeves, J | 1 |
| Morris, A | 1 |
| Cunningham, M | 1 |
| Barrett, J | 1 |
| Caramelli, B | 1 |
| Gualandro, DM | 1 |
| Freitas, S | 1 |
| Yu, PC | 1 |
| Calderaro, D | 1 |
| Keane, M | 1 |
| Bangalore, S | 1 |
| Gluud, C | 1 |
| Wetterslev, J | 1 |
| Messerli, FH | 1 |
| Rolfo, F | 1 |
| Bobbio, M | 1 |
| Angeli, F | 1 |
| Cavallini, C | 1 |
| Priebe, HJ | 1 |
| Page, C | 1 |
| Hacket, LP | 1 |
| Isbister, GK | 1 |
| Poldermans, D | 2 |
| Browne, A | 1 |
| Harvey, M | 1 |
| Cave, G | 1 |
| Chockalingam, A | 2 |
| Dellsperger, KC | 2 |
| Ramdas, S | 1 |
| Riesenberg, LA | 1 |
| Jasani, N | 1 |
| Wnek, W | 1 |
| Höcht, C | 1 |
| Opezzo, JA | 1 |
| Taira, CA | 1 |
| Sia, S | 1 |
| Ko, DT | 1 |
| Hebert, PR | 1 |
| Coffey, CS | 1 |
| Curtis, JP | 1 |
| Foody, JM | 1 |
| Sedrakyan, A | 1 |
| Krumholz, HM | 1 |
| Mountantonakis, SE | 1 |
| Moutzouris, DA | 1 |
| Tiu, RV | 1 |
| Papaioannou, GN | 1 |
| McPherson, CA | 1 |
| Fikkers, BG | 1 |
| Damen, J | 1 |
| Scheffer, GJ | 1 |
| Kruithof, HC | 1 |
| Thürmann, PA | 1 |
| Haack, S | 1 |
| Werner, U | 1 |
| Szymanski, J | 1 |
| Haase, G | 1 |
| Drewelow, B | 1 |
| Reimann, IR | 1 |
| Hippius, M | 1 |
| Siegmund, W | 1 |
| May, K | 1 |
| Hasford, J | 1 |
| Earl, GL | 1 |
| Verbos-Kazanas, MA | 1 |
| Fitzpatrick, JM | 1 |
| Narula, J | 1 |
| Tejwani, L | 1 |
| Aggarwal, K | 1 |
| Schmitto, JD | 1 |
| Hein, S | 1 |
| Bräuer, A | 1 |
| Popov, AF | 1 |
| Quintel, M | 1 |
| Schöndube, FA | 1 |
| Fleisher, LA | 1 |
| Dahlström, U | 1 |
| Berglund, U | 1 |
| Karlsson, E | 1 |
| Kulling, P | 1 |
| Wayne, VS | 1 |
| Harper, RW | 1 |
| Laufer, E | 1 |
| Federman, J | 1 |
| Anderson, ST | 1 |
| Pitt, A | 1 |
| Herlitz, J | 2 |
| Hjalmarson, A | 1 |
| Shepherd, AM | 1 |
| Lin, MS | 1 |
| Keeton, TK | 1 |
| Grubb, BP | 1 |
| Kosinski, D | 1 |
| Samoil, D | 1 |
| Pothoulakis, A | 1 |
| Lorton, M | 1 |
| Kip, K | 1 |
| Sneddon, JF | 1 |
| Scalia, G | 1 |
| Ward, DE | 1 |
| McKenna, WJ | 1 |
| Camm, AJ | 1 |
| Frenneaux, MP | 1 |
| Holmer, S | 1 |
| Rinne, B | 1 |
| Eckardt, KU | 1 |
| Le Hir, M | 1 |
| Schricker, K | 1 |
| Kaissling, B | 1 |
| Riegger, G | 1 |
| Kurtz, A | 1 |
| Berger, PB | 1 |
| Ruocco, NA | 1 |
| Ryan, TJ | 1 |
| Frederick, MM | 1 |
| Podrid, PJ | 1 |
| Sra, JS | 1 |
| Jazayeri, MR | 1 |
| Avitall, B | 1 |
| Dhala, A | 1 |
| Deshpande, S | 1 |
| Blanck, Z | 1 |
| Akhtar, M | 1 |
| Hartford, M | 1 |
| Aune, S | 1 |
| Karlsson, T | 1 |
| Alhashemi, JA | 1 |
| Hooper, J | 1 |
| Liguori, GA | 1 |
| Kahn, RL | 1 |
| Gordon, J | 1 |
| Gordon, MA | 1 |
| Urban, MK | 1 |
| Yörükoğlu, D | 1 |
| Göktug, A | 1 |
| Alanoğlu, Z | 1 |
| Tulunay, M | 1 |
| Owens, P | 1 |
| O'Brien, E | 1 |
| Shi, X | 1 |
| Wray, DW | 1 |
| Formes, KJ | 1 |
| Wang, HW | 1 |
| Hayes, PM | 1 |
| O-Yurvati, AH | 1 |
| Weiss, MS | 1 |
| Reese, IP | 1 |
| Amsterdam, EA | 1 |
| Kulcyski, J | 1 |
| Ridgeway, MG | 1 |
| Linnik, W | 1 |
| Tintinalli, JE | 1 |
| Ramos, R | 1 |
| Antman, EM | 1 |
| Dupont, WD | 1 |
| Bonalsky, J | 1 |
| Califf, RM | 1 |
| Corwin, S | 1 |
| Fink, L | 1 |
| Hansen, DE | 1 |
| Kawanishi, DT | 1 |
| Kronenberg, MW | 1 |
| McKay, CR | 1 |
| Bekes, CE | 1 |
| Scott, WE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multi-Center Study on the Metoprolol Optimal Dosing Pathway of Metoprolol Application in Chinese Patients With Acute Coronary Syndrome[NCT03413410] | 1,000 participants (Anticipated) | Interventional | 2018-02-01 | Recruiting | |||
| [NCT00000505] | Phase 3 | 0 participants | Interventional | 1983-04-30 | Completed | ||
| Predicting the Occurence of Hypotensive Bradycardic Events in the Patients Undergoing Arthroscopic Shoulder Surgery in the Sitting Position Under Interscalene Brachial Plexus Block[NCT01926561] | 68 participants (Actual) | Observational | 2011-08-31 | Completed | |||
| "PGDT With the Hypotension Prediction Index to Reduce the Number and Duration of Intraoperative Hypotension and the Incidence of Renal Failure in Patients Undergoing Lung Surgery"[NCT04149314] | 142 participants (Actual) | Interventional | 2019-11-20 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for metoprolol and Hypotension
| Article | Year |
|---|---|
[The POISE study].
Topics: Adrenergic beta-Antagonists; Bradycardia; Delayed-Action Preparations; Heart Arrest; Humans; Hyperte | 2008 |
Influence of beta-blockers on the outcome of at risk patients.
Topics: Adrenergic beta-Antagonists; Cohort Studies; Contraindications; Coronary Disease; Double-Blind Metho | 2009 |
Dynamic left ventricular outflow tract obstruction in acute myocardial infarction with shock: cause, effect, and coincidence.
Topics: Adrenergic beta-Antagonists; Aged; Algorithms; Amiodarone; Cardiac Catheterization; Diagnosis, Diffe | 2007 |
10 trials available for metoprolol and Hypotension
| Article | Year |
|---|---|
Impact of metoprolol standard dosing pathway in Chinese patients with acute coronary syndrome: protocol for a multicentre prospective study.
Topics: Acute Coronary Syndrome; Adrenergic beta-1 Receptor Antagonists; Blood Pressure; China; Dose-Respons | 2019 |
Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Dizziness; Fatig | 2004 |
Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Emergency Service, Hospital; Fema | 2006 |
Perioperative beta blockade: where do we go from here?
Topics: Adrenergic beta-Antagonists; Coronary Disease; Humans; Hypotension; Intraoperative Care; Intraoperat | 2008 |
Established beta-adrenergic receptor blocking therapy and acute myocardial infarction. A clinical study of risks and benefits.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Femal | 1980 |
Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: results from the Thrombolysis in Myocardial In
Topics: Female; Heart Failure; Humans; Hypotension; Incidence; Male; Metoprolol; Middle Aged; Myocardial Inf | 1993 |
The use of metoprolol and glycopyrrolate to prevent hypotensive/bradycardic events during shoulder arthroscopy in the sitting position under interscalene block.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arthroscopy; Bradycardia; Double-Blind Method; | 1998 |
Comparison of intravenous metoprolol, verapamil and diltiazem on the attenuation of haemodynamic changes associated with tracheal extubation.
Topics: Adult; Anti-Arrhythmia Agents; Antihypertensive Agents; Blood Pressure; Bradycardia; Diastole; Dilti | 1999 |
Efficacy of cardioselective beta-adrenergic blockade with intravenously administered metoprolol in the treatment of supraventricular tachyarrhythmias.
Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Atrial Flutter; Female; Humans; Hypotension; In | 1991 |
Early treatment with intravenous metoprolol for suspected acute myocardial infarction: a phase IV United States trial. Phase IV Metoprolol in Myocardial Infarction Study Group.
Topics: Adult; Aged; Clinical Trials as Topic; Data Collection; Female; Humans; Hypotension; Infusions, Intr | 1989 |
41 other studies available for metoprolol and Hypotension
| Article | Year |
|---|---|
Clinically Significant Bradycardia and Hypotension Following Consumption of Betel Leaf in a Patient Treated for Chronic Atrial Fibrillation.
Topics: Aged; Atrial Fibrillation; Bradycardia; Diabetes Mellitus, Type 2; Female; Humans; Hypotension; Meto | 2023 |
Intravenous Metoprolol Versus Diltiazem for Rate Control in Atrial Fibrillation.
Topics: Atrial Fibrillation; Bradycardia; Calcium Channel Blockers; Diltiazem; Heart Rate; Humans; Hypotensi | 2022 |
Short-Term Results of Ivabradine versus Metoprolol: The Effects on Atrial Fibrillation in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting.
Topics: Atrial Fibrillation; Coronary Artery Bypass; Humans; Hypotension; Ivabradine; Metoprolol; Postoperat | 2022 |
Comparison of new-onset post-operative atrial fibrillation between patients receiving carvedilol and metoprolol after off-pump coronary artery bypass graft surgery.
Topics: Adrenergic beta-Antagonists; Adult; Atrial Fibrillation; Bradycardia; Carvedilol; Coronary Artery By | 2023 |
Acute rate control with metoprolol versus diltiazem in atrial fibrillation with heart failure with reduced ejection fraction.
Topics: Adult; Atrial Fibrillation; Cohort Studies; Diltiazem; Heart Failure; Heart Rate; Humans; Hypotensio | 2023 |
Social stress is lethal in the mdx model of Duchenne muscular dystrophy.
Topics: Adrenergic beta-Antagonists; Animals; Arterial Pressure; Disease Models, Animal; Dystrophin; Gait Di | 2020 |
Persistent Hyperinsulinemia Following High-Dose Insulin Therapy: A Case Report.
Topics: Adrenergic beta-1 Receptor Antagonists; Amlodipine; Bradycardia; Calcium Channel Blockers; Drug Admi | 2020 |
Age Does Not Affect Metoprolol's Effect on Perioperative Outcomes (From the POISE Database).
Topics: Adrenergic beta-1 Receptor Antagonists; Age Factors; Aged; Aged, 80 and over; Databases, Factual; Fe | 2018 |
A Young Woman with Bradycardia and Hypotension.
Topics: Adrenergic beta-1 Receptor Antagonists; Analgesics, Opioid; Benzodiazepines; Bradycardia; Central Ne | 2018 |
Beta blocker therapy in recipients of twin-to-twin transfusion syndrome.
Topics: Adrenergic beta-1 Receptor Antagonists; Cardiac Output, Low; Echocardiography; Female; Fetofetal Tra | 2019 |
Safety of intravenous metoprolol use in unmonitored wards: a single-centre observational study.
Topics: Adrenergic beta-Antagonists; Aged; Dose-Response Relationship, Drug; Heart Rate; Hospitals, Private; | 2015 |
Beta-blocker therapy in non-cardiac surgery.
Topics: Adrenergic beta-Antagonists; Bradycardia; Cardiovascular Diseases; Causality; Comorbidity; Humans; H | 2008 |
Beta-blocker therapy in non-cardiac surgery.
Topics: Adrenergic beta-Antagonists; Bradycardia; Cardiovascular Diseases; Delayed-Action Preparations; Huma | 2008 |
Perioperative beta blockade.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Comorbidity; Humans; Hypotension; Intraoperative Compl | 2008 |
The use of high-dose insulin-glucose euglycemia in beta-blocker overdose: a case report.
Topics: Adrenergic beta-Antagonists; Antidotes; Blood Glucose; Blood Pressure; Critical Care; Drug Administr | 2009 |
The experts debate: perioperative beta-blockade for noncardiac surgery--proven safe or not?
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Humans; Hypotension; Metoprolol; Myocardial In | 2009 |
Intravenous lipid emulsion does not augment blood pressure recovery in a rabbit model of metoprolol toxicity.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Arteries; Blood Pressure; Disease Mod | 2010 |
Isolated dynamic left ventricular outflow tract obstruction can cause hypotension that rapidly responds to intravenous beta blockade.
Topics: Adrenergic beta-Antagonists; Aged; Critical Care; Echocardiography, Doppler; Female; Heart Rate; Hum | 2011 |
Drug overdose with refractory bradycardia and hypotension.
Topics: Antihypertensive Agents; Bradycardia; Clonazepam; Diltiazem; Drug Overdose; Female; GABA Modulators; | 2011 |
[The use of intra-aortic balloon counterpulsation in the treatment of severe hemodynamic instability from myocardial depressant drug overdose].
Topics: Adult; Antihypertensive Agents; Bradycardia; Counterpulsation; Diltiazem; Drug Overdose; Fatal Outco | 2003 |
Anterior hypothalamic beta-adrenergic activity in the maintenance of hypertension in aortic coarctated rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anterior Hypothalamic Nucleus; Aorti | 2004 |
Plasma concentrations of epinephrine need to be monitored in study of incidence of hypotensive/bradycardic events.
Topics: Bradycardia; Epinephrine; Humans; Hypotension; Intraoperative Complications; Metoprolol; Monitoring, | 2004 |
Thoracic epidural analgesia and antihypertensive therapy: a matter of timing?
Topics: Aged; Analgesia, Epidural; Analgesics, Opioid; Anesthetics, Local; Antihypertensive Agents; Bupivaca | 2006 |
Tolerability of beta-blockers metabolized via cytochrome P450 2D6 is sex-dependent.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Bradycardia; Cytochrome P-450 CYP2D6; Dose-Res | 2006 |
Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Blood Pressure; Carbazoles; Cardiac Output, | 2007 |
Perioperative myocardial infarction after cesarean section in a young woman with hypertrophic obstructive cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Anesthetics, Local; | 2008 |
Clinical experiences with prenalterol as an antidote to Beta-adrenoceptor blockade.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Anesthesia; Cardiac Catheterizat | 1982 |
Adverse interaction between beta-adrenergic blocking drugs and verapamil--report of three cases.
Topics: Adrenergic beta-Antagonists; Aged; Bradycardia; Coronary Disease; Drug Interactions; Drug Therapy, C | 1982 |
Relationship between electrocardiographically estimated infarct size and clinical findings in anterior myocardial infarction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Electrocardiography; Heart Failure; Humans; Hypotension; Length o | 1984 |
Hypoglycemia-induced hypertension in a diabetic patient on metoprolol.
Topics: Blood Glucose; Blood Pressure; Diabetes Mellitus; Epinephrine; Humans; Hypoglycemia; Hypotension; Ma | 1981 |
Postpartum syncope.
Topics: 1-Naphthylamine; Administration, Oral; Adolescent; Adult; Diagnosis, Differential; Disopyramide; Dos | 1995 |
Exercise induced vasodepressor syncope.
Topics: Adolescent; Adult; Aged; Cardiac Output; Disopyramide; Exercise; Exercise Test; Female; Heart Rate; | 1994 |
Role of renal nerves for the expression of renin in adult rat kidney.
Topics: Analysis of Variance; Animals; Denervation; Enzyme Precursors; Fluorescent Antibody Technique; Gene | 1994 |
Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole.
Topics: Adolescent; Adult; Aged; Bradycardia; Cardiac Pacing, Artificial; Disopyramide; Female; Follow-Up St | 1993 |
Occurrence of hypotension during streptokinase infusion in suspected acute myocardial infarction, and its relation to prognosis and metoprolol therapy.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Female; Humans; Hypotension; Male; Metoprolol; Middl | 1993 |
Treatment of milrinone-associated tachycardia with beta-blockers.
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia, Epidural; Anesthesia, General; Anti-Arrhythmia Agents | 1998 |
Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Atenolol; Blood Pressure Monitoring, Amb | 1999 |
Beta-blockers for heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Heart Failure; Humans; | 2000 |
Orthostatic hypotension in aging humans.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Atropine; Blood Pressure; Female; Glycopyrrolate; H | 2000 |
Associated reactions during and immediately after rtPA infusion.
Topics: Arrhythmias, Cardiac; Drug Hypersensitivity; Drug Therapy, Combination; Emergencies; Hemorrhage; Hum | 1989 |
Occult metoprolol overdose.
Topics: Adult; Diagnosis, Differential; Emergencies; Epinephrine; Female; Humans; Hypotension; Metoprolol | 1985 |